Ivabid OD 15mg Tablet

Description

Ivabid OD 15mg Tablet contains Ivabradine 15mg, a once-daily extended-release heart medicine used for managing chronic stable angina and chronic heart failure with reduced ejection fraction (HFrEF). The OD (once daily) formulation provides a sustained therapeutic effect throughout the day with a single dose.

Ivabradine selectively inhibits the If (“funny”) channels in the sinoatrial node, which is the natural pacemaker of the heart. This action slows the heart rate without affecting the strength of heart contraction or blood pressure, improving oxygen supply to the heart and reducing symptoms of angina and heart failure.

The 15mg strength is typically prescribed for patients who require higher heart rate control after lower doses (5mg or 10mg) are not sufficient.

---

Uses

• Management of chronic stable angina pectoris

• Treatment of chronic heart failure with reduced ejection fraction

• Improves exercise tolerance and daily activity capacity

• Helps reduce hospitalization risk in heart failure patients

---

How It Works

• Ivabradine slows heart rate by selectively blocking If channels in the sinoatrial node.

• Reduces oxygen demand of the heart while maintaining cardiac output.

• Relieves angina symptoms and prevents progression of heart failure.

• Extended-release formulation ensures steady therapeutic effect for 24 hours.

---

Benefits

• Once-daily dosing for convenience and adherence

• Reduces frequency and severity of angina attacks

• Improves exercise capacity and heart efficiency

• Reduces hospitalization risk in chronic heart failure

• Suitable for patients who require stronger heart rate reduction

---

Directions for Use

• Take the tablet once daily, preferably with food.

• Swallow whole; do not crush or chew.

• Heart rate and ECG monitoring recommended during treatment.

• Dose adjustments may be required based on clinical response and heart rate.

---

Safety Information

• Common side effects: bradycardia (slow heart rate), dizziness, fatigue, headache, visual disturbances (phosphenes).

• Avoid in patients with severe liver impairment, sick sinus syndrome, acute decompensated heart failure, or pacemaker dependency.

• Not recommended during pregnancy or breastfeeding unless prescribed.

• Avoid grapefruit juice and alcohol, which may increase drug levels.

• Possible interactions with diltiazem, verapamil, antifungals, macrolide antibiotics, and HIV antivirals.